No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

Ursomaxe Tablet | Pharmacountry

Products
Finished Dosage Forms
Tablets
Immediate-Release Tablets

Ursomaxe Tablet

Saint Corporation

Distributor · Finished Dosage FormsRepublic of Korea

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Tablets / Immediate-Release Tablets

Trade Type

Sell

Product Name

Ursomaxe Tablet

Details

Ursodeoxycholic Acid

Substance

Ursodeoxycholic Acid

Manufacturer(s)

Korea Arlico Pharm Co., Ltd. - Republic of Korea

Registered Market

Viet Nam

Specifications

Dosage Form: Tablet film-coated
Packaging: Box 3 blister x 10 tablet
Strength: 200mg
Standards: Current BP
Shelf Life: 36 month

Documents

Drug Marketing Authorization Number

Document No.: 880110042625

Issue Date: Jan 22, 2025

Expiry Date: Jan 22, 2028

Note: 64/QĐ-QLD | 124,2